QT
KRYS icon

Quantbot Technologies’s Krystal Biotech KRYS Stock Holding History

Quantbot Technologies’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
305
+172
+129% +$51.4K ﹤0.01% 1430
2026
Q1 		$34.4K Buy
133
+47
+55% +$12.5K ﹤0.01% 1452
2025
Q4 		$21.2K Buy
+86
New +$18.1K ﹤0.01% 1565
2024
Q2 		– Sell
-137
Closed -$24.4K – 1694
2024
Q1 		$24.4K Buy
+137
New +$19K ﹤0.01% 1397
2021
Q4 		– Sell
-100
Closed -$5K – 1718
2021
Q3 		$5K Sell
100
-100
-50% -$5.92K ﹤0.01% 1410
2021
Q2 		$13K Buy
+200
New +$14K ﹤0.01% 1278

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quantbot Technologies's KRYS Position: Q2 2026 in Review

Quantbot Technologies increased its Krystal Biotech (KRYS) stake by 129% in Q2 2026, buying an estimated $51.4K and bringing the position to 305 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Quantbot Technologies first reported a position in KRYS in Q2 2021 and has held it in 6 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Quantbot Technologies held 305 shares of Krystal Biotech worth $113K as of Q2 2026.
  • Quantbot Technologies bought 172 Krystal Biotech shares in Q2 2026, an estimated $51.4K.
  • Krystal Biotech made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1430 holding.
  • Quantbot Technologies first reported a position in Krystal Biotech in Q2 2021 and has held it in 6 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.